The Healthium Medtech IPO Date Will Be Updated Soon. Read the post to learn about Healthium Medtech IPO GMP.
Healthism Medtech is a multinational medical technology firm specializing in chronic, post-surgery, and surgical care. The company’s vision is to provide every patient worldwide access to precision medical technology products.
Start your investing journey today. Find the latest information on Upcoming IPOs.
Key Details Of Healthium Medtech IPO:
Bidding Dates
Coming Soon
Price Range
₹0 per share
Face Value
₹0 per share
GMP
₹0
Healthium Medtech GMP
The Healthium Medtech IPO GMP is ₹[].
Healthium Medtech IPO Overview
Healthium Medtech Ltd, the country’s second-largest medical consumables and surgical sutures company, has filed draft papers with SEBI to raise funds via an initial public offering (IPO) worth Rs. 390 crores and an offer for sale of up to 39.10 million shares by existing shareholders and promoters. The OFS will comprise the sale of 39 million shares by Quinag Acquisition (FDI) and up to 100,000 shares by Mahadevan Narayanamoni. Currently, Quinag Acquisition FDI holds a 99.79% stake in the firm.
Healthium Medtech IPO Financials
| Particulars | 2021 | 2020 | 2019 |
| Revenue from operations (₹ million) | 7,133.57 | 6,391.79 | 5,840.20 |
| Restated profit before tax (₹ million) | 1,130.33 | 578.81 | 243.04 |
| Restated profit for the year (₹ million) | 854.28 | 367.60 | 137.31 |
| Gross margin (%) | 62.33% | 65.89% | 65.26% |
| EBITDA (₹) | 1,539.27 | 955.74 | 544.27 |
| EBITDA margin (%) | 21.58% | 14.95% | 9.32% |
| ROE (%) | 21.57% | 10.98% | 3.57% |
| ROCE (%) | 22.98% | 16.08% | 6.45% |
| Cash conversion cycle (in days) | 139 | 171 | 219 |
| Net cash flow from operating activities (₹ million) | 1,221.29 | 589.24 | 514.38 |
Company Profile
The brand has a fantastic commercial presence and market access in India and the UK. They export goods to more than 80 nations, including South America, Asia, and America, as well as the US, UK, Germany, and France (established markets). The brand stands out from its competitors because of its extensive selection of high-quality products at enticing prices. The company’s quality and value proposition aligns with the focus of healthcare stakeholders such as governments, hospitals, payers and surgeons on improving the affordability of and access to quality healthcare. Further, its well-established corporate and product brands and relationships with hospitals, surgeons and distributors create competitive advantages for its business.
IPO Strengths
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
Healthium Medtech FAQs
When will the Healthium Medtech IPO allotment be available?
Details are not available.
What will be the Healthium Medtech IPO lot size?
Details are not available.
What minimum lot size can retail investors subscribe to?
The minimum investment size is one lot for retail investors.
When will Healthium Medtech IPO open for subscription?
Details are not available.
What is the size of Healthium Medtech IPO?
Details are not available.
Is it necessary to approve a UPI mandate request immediately?
Approving the UPI payment is the final step of the IPO application. You will get T+1 days to approve the payment mandate in your UPI id.
Leave a Reply